Innovation Breakfast Session Sponsored by Exosome Diagnostics and Labcorp
Title: The Role of the ExoDx™ Prostate Test for Early Detection of Prostate Cancer in Primary Care
Speaker: Judd Moul, MD, Urology Professor at the Duke Cancer Institute and Duke University Medical
Details: Learn how to enhance the physician-patient shared decision to proceed to biopsy with the ExoDxTM Prostate urine test, a non-invasive prostate cancer risk assessment tool, which has been included in the National Comprehensive Cancer Network Guidelines® since May 2019.
When: Friday, July 8, 7:15-8:15 a.m. in the Royal Ballroom I - V.
CLICK HERE to add this program to your existing registration.